Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Docetaxel News Monitoring

Get by Email • RSS

Published on May 3, 2025

Optimizing Patient Selection and Treatment Timing with Emerging Intravesical Therapies: The Case of Nadofaragene ...

Read the Full Video Transcript Sam Chang: Hi, I'm Sam Chang. I'm a urologist in Nashville, Tennessee, and it's always a pleasure when I get to spend some time with some superstars. And Patrick Hensley from the University of Kentucky is truly …

Source: UroToday - Neutral
Published on May 2, 2025

Oscotec wins FDA nod for anti-resistance cancer trial, drops oral denfivontinib over safety issues

Oscotec is placing its bets on anti-resistance cancer therapies. The Korean biotech received the U.S. FDA green light to go ahead with a phase 1 trial for OCT-598, a dual EP2/EP4 antagonist designed to cut off tumor regrowth signals triggered by cell …

Source: Korea Biomedical Review - Neutral
Published on May 1, 2025

Biomarkers for Gemcitabine Docetaxel in Non-Muscle Invasive Bladder Cancer - Vignesh Packiam

Read the Full Video Transcript Joep de Jong: Hi, everybody. My name is Joop de Jong from the Erasmus University Medical Center in the Netherlands. I'm here today in Las Vegas at AUA 2025, and we are very thankful for UroToday to be hosting this …

Source: UroToday - Neutral
Published on May 1, 2025

This Week’s Biopharma News: AstraZeneca Cans Phase III Trial

Credit: Adobestock.com The big business announcements: AstraZeneca axes phase III prostate cancer trial AstraZeneca is discontinuing a phase III trial of Truqap (capivasertib) in combination with docetaxel and androgen-deprivation therapy (ADT) in …

Source: The Medicine Maker - Neutral
Published on May 1, 2025

Solihull mom to Race for Life after cancer treatment led to dream wedding

Watch more of our videos on ShotsTV.com and on Freeview 262 or Freely 565 Visit Shots! now A mum who found a cancerous lump while breastfeeding says research has enabled her to marry the man of her dreams. Tumi Westwood from Solihull believed one of her …

Source: BirminghamWorld - Pending
Published on Apr 30, 2025

Improving Outcomes with Combination Therapies for PSMA Radioligand Treatment "Presentation" - Michael Hofman

Read the Full Video Transcript Michael Hofman: For the invitation today. This afternoon, I'm going to be talking on improving outcomes with combination therapies. It's actually-- this year will be our 10th year anniversary since we did our first …

Source: UroToday - Neutral
Published on Apr 30, 2025

Advances in Current Treatment Paradigms for Metastatic Hormone-Sensitive Prostate Cancer.

Metastatic hormone-sensitive prostate cancer (mHSPCa) presents de novo or represents significant disease progression and requires systemic treatment. However, progression to castration resistance is inevitable. The treatment landscape has evolved with the …

Source: UroToday - Neutral
Published on Apr 30, 2025

AstraZeneca’s Truqap fails in another Phase III trial

AstraZeneca has discontinued a Phase III trial of Truqap (capivasertib) after a review concluded that the study was unlikely to meet its endpoints. The CAPItello-280 study (NCT05348577) was investigating Truqap in combination with docetaxel and androgen- …

Source: Clinical Trials Arena - Pending
Published on Apr 30, 2025

The future of NSCLC treatment: what’s in store for the therapeutic space?

Newsletter Signup - Under Article / In Page "*" indicates required fields For decades, non-small cell lung cancer (NSCLC) stood as one of the formidable challenges in oncology, often diagnosed late and treated with limited options. But now, …

Source: Labiotech - Neutral
Published on Apr 30, 2025

Investigators Discontinue Trial Assessing Capivasertib in Metastatic CRPC

Developer AstraZeneca has announced the discontinuation of the phase 3 CAPItello-280 trial (NCT05348577) evaluating capivasertib (Truqap) plus docetaxel and androgen deprivation therapy (ADT) among patients with metastatic castration-resistant prostate …

Source: Cancer Network - New Jersey - Pending
Published on Apr 30, 2025

AstraZeneca's highly touted Truqap flunks another phase 3 trial

AstraZeneca has come up short in another phase 3 trial of the AKT inhibitor Truqap, raising more questions about the blockbuster potential of the first-in-class cancer treatment. Alongside its first-quarter earnings report, AZ revealed that an interim …

Source: Fierce Pharma - Neutral
Published on Apr 30, 2025

AstraZeneca discontinues Phase 3 trial of Truqap in metastatic castration-resistant prostate cancer

AstraZeneca has announced the discontinuation of the CAPItello-280 Phase III trial evaluating the efficacy and safety of Truqap (capivasertib) in combination with docetaxel and androgen-deprivation therapy (ADT) compared to docetaxel and ADT with placebo …

Source: Medical Dialogues - Indeterminate
Published on Apr 30, 2025

AstraZeneca to discontinue CAPItello-280 phase III trial of Truqap in metastatic castration-resistant prostate cancer

AstraZeneca is discontinuing the CAPItello-280 phase III trial evaluating the efficacy and safety of Truqap (capivasertib) in combination with docetaxel and androgen-deprivation therapy (ADT) compared to docetaxel and ADT with placebo in patients with …

Source: Pharmabiz.com - Neutral
Published on May 1, 2025

KN026/Chemo Meets PFS End Point in HER2+ Gastric Cancer in 2L Setting

KN026, an anti-HER2 bispecific antibody, administered with chemotherapy met the pre-specified primary end point of progression-free survival (PFS) with statistical significance and clinical relevance in the second-line or above treatment of patients with …

Source: Cancer Network - New Jersey - Pending
Published on May 1, 2025

BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel

Read the Full Video Transcript Pedro Barata: Hello, everyone. I'm Pedro Barata. I'm a GU oncologist out of University Hospitals in Cleveland, Ohio. We're here at AUA 2025. I'm very, very happy to have the chance to sit down with Dr. Manish …

Source: UroToday - Neutral
Published on May 1, 2025

KN026 Plus Chemo Improves PFS in Pretreated HER2+ Gastric/GEJ Cancer

The addition of the anti-HER2 bispecific antibody KN026 to chemotherapy demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared with placebo plus chemotherapy in patients with HER2-positive …

Source: OncLive - Pending
Published on Apr 28, 2025

Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and ...

- FHD-909 (LY4050784) advancing in Phase 1 trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population - Preclinical synergistic anti-tumor activity of FHD-909 in combination with pembrolizumab and KRAS …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on Mar 21, 2018

Human medicines European public assessment report (EPAR): Xeloda, capecitabine, Date of authorisation: 02/02/2001, ...

Colon cancer In colon cancer, Xeloda on its own has been shown to be as effective as the combination of fluorouracil and folinic acid (a medicine that enhances the effects of fluorouracil) in a main study involving 1,987 patients who had had surgery for …

Source: European Medicines Agency - Pending
Published on May 1, 2025

Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference

WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board, and Matt Pulisic, CFO, will …

Distribution channels: Culture, Society & Lifestyle, Technology ...

02 days 02:49:01

Featured Releases

Got News to Share? · Submit · See All

Published on May 2, 2025 - 14:54 GMT

Zinc Chloride Market Poised for 5.0% CAGR Growth: Increasing Demand in Batteries, Water Treatment, and Pharmaceuticals

The global zinc chloride market is set to grow from USD 341.3 million in 2025 to USD 556.0 million by 2035, expanding at a CAGR of 5.0%. NEWARK, DE, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- The global zinc chloride market is projected to …

Distribution channels: Chemical Industry ...
Published on May 2, 2025 - 20:42 GMT

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia and BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …

Distribution channels:

Published on May 2, 2025 - 20:05 GMT

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 20:30 GMT

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO Calif. and SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that …

Distribution channels: Technology ...

Published on May 2, 2025 - 20:05 GMT

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on May 1, 2025 the Company granted inducement awards to purchase up …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 20:01 GMT

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NAARDEN, the Netherlands and MIAMI, May 02, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 17:48 GMT

Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) Seeking Recovery for Investors – Contact Levi & ...

NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE: ATNM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit …

Distribution channels: Consumer Goods, Law ...
Published on May 2, 2025 - 12:00 GMT

ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand ...

Agreement builds on landmark licensing deal between ARS Pharma and ALK-Abelló A/S, which provided ARS Pharma with $145 million upfront and ALK with commercialization rights to neffy in Canada, United Kingdom, European Union and certain other countries …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 809,271,680 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 04/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on May 3, 2025 - 21:35 GMT

Inside “Who Do You Think You Are?,” Marie Antonette Waite's Book Changing Lives

SAN DIEGO, CA, UNITED STATES, May 3, 2025 /⁨EINPresswire.com⁩/ -- Nothing defines and sets apart an excellent book than realizing that the author wrote it from the heart. Not from impulsive emotions or for-the-sake-of, but from goodwill and …

Distribution channels: Book Publishing Industry, Business & Economy ...
Published on May 3, 2025 - 21:31 GMT

Boyd Industries Appoints Stephen Goldy as VP of Sales to Drive Strategic Growth

Boyd Industries names a proven sales leader to drive national expansion in dental and ENT markets. Meet Stephen Goldy, new Vice President of Sales. CLEARWATER, FL, UNITED STATES, May 3, 2025 /⁨EINPresswire.com⁩/ -- Boyd Industries, a leading …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...
Published on May 3, 2025 - 18:58 GMT

Vannin Healthcare pledges £50 MILLION of medical consumables to strengthen disease response across Africa

Landmark Humanitarian Commitment by Vannin Healthcare Targets Critical Supply Shortages Across Africa LONDON, UNITED KINGDOM, May 3, 2025 /⁨EINPresswire.com⁩/ -- Vannin Healthcare today announced a significant, long-term humanitarian commitment, …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...
Published on May 3, 2025 - 18:49 GMT

Lizz Russell Hosts 13th Annual 'Compassion and Fashion' Event in Honor of GBS/CIDP Awareness Month

Celebrating Resilience, Raising Awareness, and Honoring 40 Years of Triumph Over GBS Through Fashion and Advocacy ESCONDIDO, CA, UNITED STATES, May 3, 2025 /⁨EINPresswire.com⁩/ -- Celebrated designer, advocate, and GBS survivor Lizz Russell is proud to …

Distribution channels: Beauty & Hair Care, Conferences & Trade Fairs ...
Published on May 3, 2025 - 18:46 GMT

Dr. Mohana Rao Patibandla Honored as Best Minimally Invasive Keyhole Neurosurgeon and Spine Surgeon - Times of India

Dr. Rao’s groundbreaking techniques in keyhole neurosurgery, endovascular neurosurgery, and spine surgery have earned him top recognition in The Times of India. GUNTUR, ANDHRA PRADESH, INDIA, May 4, 2025 /⁨EINPresswire.com⁩/ -- Dr. Mohana Rao Patibandla …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...
Published on May 3, 2025 - 18:22 GMT

National Data Reveals Rising Teen Anxiety, Depression due to Social Media Usage

Social media harms U.S. teens' mental health; rising anxiety and depression drive demand for adolescent mental health residential treatment centers. CA, UNITED STATES, May 3, 2025 /⁨EINPresswire.com⁩/ -- Robust research underscores the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 3, 2025 - 19:07 GMT

Best Supplements For Muscle Growth: Top Legal Bodybuilding Supplements & Anabolic Steroids For Bulking, Cutting & ...

Glasgow, May 03, 2025 (GLOBE NEWSWIRE) -- Achieving serious muscle growth demands more than just time in the gym. While consistent training and a solid nutrition plan form the foundation, supplements can offer an added edge. For athletes and bodybuilders, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 3, 2025 - 18:53 GMT

Mitolyn Reviews 2025: Exploring Faux Reviews, Consumer Complaints, & How to Buy Real Mitolyn Purple Peel Exploit!

Seattle, May 03, 2025 (GLOBE NEWSWIRE) -- As more individuals become health-conscious, and as stimulants continue to be avoided due to health concerns, it should come as no surprise that more people are searching out natural and safe alternatives to manage …

Distribution channels:
Published on May 3, 2025 - 18:36 GMT

Buy Ibutamoren MK 677 SARMS for Sale Online: MK-677 Before After Results - Where to Order Legal Ibutamoren SARM OTC, ...

New York City, May 03, 2025 (GLOBE NEWSWIRE) -- If you’re serious about packing on size, crushing PRs, and building a physique that commands attention, chances are you’ve heard of Ibutamoren MK-677. Legal Ibutamoren MK 677 is now available for sale online. …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 3, 2025 - 18:29 GMT

Bioma Review 2025: Revolutionizing Gut Health or Just Another Fad? Honest Analysis Inside By Bioma Probiotic!

New York City, May 03, 2025 (GLOBE NEWSWIRE) -- The scientific discussion about gut health has become the dominant topic within today's health conversation network. Scientists understand now that the digestive system plays an essential role in …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 3, 2025 - 00:15 GMT

Breakthrough research from SAWC Spring/WHS: Outcomes between ray and TMA patients with forefoot pathology

MedStar Georgetown study finds 98% overall limb salvage rate for both procedures, with similar functional and quality of life scores. GRAPEVINE, TX, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- A retrospective cohort study by MedStar Georgetown …

Distribution channels: Conferences & Trade Fairs, Education ...
Published on May 3, 2025 - 00:15 GMT

Data with topical pravibismane for infected chronic diabetic foot ulcers in first-to-podium research at SAWC Spring/WHS

Microbion Phase 2 study shows favorable safety and early efficacy data, with 46.7% of patients treated achieving complete wound closure. GRAPEVINE, TX, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- A Microbion Corporation exploratory Phase 2a study …

Distribution channels: Conferences & Trade Fairs, Education ...
Published on May 3, 2025 - 00:15 GMT

Multicenter study on Mechanical Thrombectomy (MT) in first-to-podium research at SAWC Spring/WHS

McLaren Health System reports positive outcomes in patients with advanced venous disease. GRAPEVINE, TX, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- A comprehensive, multicenter retrospective study showed positive findings evaluating the safety and …

Distribution channels: Conferences & Trade Fairs, Education ...
Published on May 3, 2025 - 09:35 GMT

SlimJaro Canada, Australia, UK, Reviews, Official Website, Discount Code, Trustpilot Complaints

Lakeland, FL, May 03, 2025 (GLOBE NEWSWIRE) -- SlimJaro Canada: The Revolutionary Fat-Burning Formula Redefining Weight Management: Imagine a world where shedding stubborn fat doesn’t involve grueling diets, endless gym sessions, or questionable “miracle” …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 3, 2025 - 08:45 GMT

Javy Protein Coffee Under Review: Best Protein Coffee with Premium Ingredients by Javy Protein Coffee

Summerville, South Carolina, May 03, 2025 (GLOBE NEWSWIRE) -- As we begin to age, there are two things that is common in terms of addiction and needs and those are the urge to drink coffee and the need to eat the right amount of protein. The older we get …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 19:38 GMT

The Springs of Ballentine to Open New Memory Care Community in Fuquay-Varina, NC

A new chapter in compassionate care is set to begin as The Springs of Ballentine, a thoughtfully designed memory care community, opens its doors on May 8, 2025 FUQUAY-VARINA, NC, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- The Springs of …

Distribution channels: Building & Construction Industry, Companies ...
Published on May 3, 2025 - 07:29 GMT

Nitric Boost Ultra Reviews and Complaints: What You Need to Know About This Male Performance Powder (Consumers Report)

OMAHA, Neb., May 03, 2025 (GLOBE NEWSWIRE) -- Let’s be honest: most guys have seen supplements that promise everything—more energy, better circulation, improved stamina, and a boost in the bedroom. They all sound the same. So why are over 43,000 men …

Distribution channels:
Published on May 2, 2025 - 19:22 GMT

Global IT Signs Managed Services Agreement with Alzheimer’s Los Angeles

Partnership Aims to Enhance Operational Efficiency and Support Mission-Driven Technology Solutions for Alzheimer’s Los Angeles LOS ANGELES, CA, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- Global IT, a top-tier provider of Managed IT …

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 19:14 GMT

Groundbreaking Ceremony for School-Based Health Center in Piketon, Ohio

New Facility To Serve Students, Community PIKETON, OH, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- The Scioto Valley Local School District, alongside Valley View Health Centers, recently held a groundbreaking ceremony for a transformative $ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 19:00 GMT

AST Announces the Return of the IP3 for 2025 – A Unique Patent Purchase and Licensing Opportunity for Patent Owners

AST announces its tenth annual Industry Patent Purchase and Licensing Program - IP3 2025, connecting patent owners with major global technology firms. PRINCETON, NJ, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- Allied Security Trust (AST) is …

Distribution channels: Automotive Industry, Banking, Finance & Investment Industry ...